Nls Pharmaceutics Ag Stock Price Prediction
| NLSPW Stock | USD 0.01 0 18.18% |
Oversold Vs Overbought
51
Oversold | Overbought |
Using NLS Pharmaceutics hype-based prediction, you can estimate the value of NLS Pharmaceutics AG from the perspective of NLS Pharmaceutics response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in NLS Pharmaceutics to buy its stock at a price that has no basis in reality. In that case, they are not buying NLS because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
NLS Pharmaceutics after-hype prediction price | USD 0.0106 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
NLS |
NLS Pharmaceutics After-Hype Price Prediction Density Analysis
As far as predicting the price of NLS Pharmaceutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in NLS Pharmaceutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of NLS Pharmaceutics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
NLS Pharmaceutics Estimiated After-Hype Price Volatility
In the context of predicting NLS Pharmaceutics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on NLS Pharmaceutics' historical news coverage. NLS Pharmaceutics' after-hype downside and upside margins for the prediction period are 0.00 and 36.33, respectively. We have considered NLS Pharmaceutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
NLS Pharmaceutics is out of control at this time. Analysis and calculation of next after-hype price of NLS Pharmaceutics is based on 3 months time horizon.
NLS Pharmaceutics Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as NLS Pharmaceutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading NLS Pharmaceutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with NLS Pharmaceutics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
4.54 | 36.32 | 0.02 | 0.08 | 3 Events / Month | 3 Events / Month | In about 3 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
0.01 | 0.01 | 18.05 |
|
NLS Pharmaceutics Hype Timeline
NLS Pharmaceutics is now traded for 0.01. The entity has historical hype elasticity of 0.02, and average elasticity to hype of competition of 0.08. NLS is projected to increase in value after the next headline, with the price projected to jump to 0.0106 or above. The average volatility of media hype impact on the company the price is over 100%. The price increase on the next news is projected to be 18.05%, whereas the daily expected return is now at 4.54%. The volatility of related hype on NLS Pharmaceutics is about 201777.78%, with the expected price after the next announcement by competition of 0.09. NLS Pharmaceutics AG has accumulated 1.63 M in total debt. NLS Pharmaceutics has a current ratio of 0.05, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Note, when we think about NLS Pharmaceutics' use of debt, we should always consider it together with its cash and equity.Assuming the 90 days horizon the next projected press release will be in about 3 days. Check out NLS Pharmaceutics Basic Forecasting Models to cross-verify your projections.NLS Pharmaceutics Related Hype Analysis
Having access to credible news sources related to NLS Pharmaceutics' direct competition is more important than ever and may enhance your ability to predict NLS Pharmaceutics' future price movements. Getting to know how NLS Pharmaceutics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how NLS Pharmaceutics may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| ELYM | Eliem Therapeutics | 0.25 | 4 per month | 0.00 | (0.19) | 6.21 | (9.35) | 34.87 | |
| SCPH | Scpharmaceuticals | (0.1) | 7 per month | 0.00 | (0.21) | 4.05 | (7.09) | 20.70 | |
| MIST | Milestone Pharmaceuticals | 0.05 | 7 per month | 1.61 | 0.09 | 7.19 | (2.11) | 18.66 | |
| MCRB | Seres Therapeutics | (0.06) | 9 per month | 5.66 | 0.02 | 10.84 | (9.78) | 28.84 | |
| LUMO | Lumos Pharma | (0.05) | 6 per month | 2.72 | 0.05 | 5.95 | (5.19) | 16.25 |
NLS Pharmaceutics Additional Predictive Modules
Most predictive techniques to examine NLS price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for NLS using various technical indicators. When you analyze NLS charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About NLS Pharmaceutics Predictive Indicators
The successful prediction of NLS Pharmaceutics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as NLS Pharmaceutics AG, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of NLS Pharmaceutics based on analysis of NLS Pharmaceutics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to NLS Pharmaceutics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to NLS Pharmaceutics's related companies.
Story Coverage note for NLS Pharmaceutics
The number of cover stories for NLS Pharmaceutics depends on current market conditions and NLS Pharmaceutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that NLS Pharmaceutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about NLS Pharmaceutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
NLS Pharmaceutics Short Properties
NLS Pharmaceutics' future price predictability will typically decrease when NLS Pharmaceutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of NLS Pharmaceutics AG often depends not only on the future outlook of the potential NLS Pharmaceutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. NLS Pharmaceutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 38.2 M | |
| Cash And Short Term Investments | 897.7 K |
Additional Tools for NLS Stock Analysis
When running NLS Pharmaceutics' price analysis, check to measure NLS Pharmaceutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NLS Pharmaceutics is operating at the current time. Most of NLS Pharmaceutics' value examination focuses on studying past and present price action to predict the probability of NLS Pharmaceutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NLS Pharmaceutics' price. Additionally, you may evaluate how the addition of NLS Pharmaceutics to your portfolios can decrease your overall portfolio volatility.